These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report. Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163 [TBL] [Abstract][Full Text] [Related]
3. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature. Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965 [TBL] [Abstract][Full Text] [Related]
4. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report. Iesaka H; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Abe T; Shinohara N; Atsumi T Medicine (Baltimore); 2023 Dec; 102(51):e36664. PubMed ID: 38134115 [TBL] [Abstract][Full Text] [Related]
5. [A Case of Isolated ACTH Deficiency Induced by Nivolumab in a Patient with Gastric Cancer Metastasis of the Peritoneum]. Mashita N; Otake K; Nonogaki A; Saito H; Nakamura M; Yamanaka M; Tobinaga J; Ishigure K Gan To Kagaku Ryoho; 2019 Dec; 46(12):1879-1882. PubMed ID: 31879407 [TBL] [Abstract][Full Text] [Related]
6. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases]. Gu YC; Liu Y; Xie C; Cao BS Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206 [TBL] [Abstract][Full Text] [Related]
7. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review. Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581 [TBL] [Abstract][Full Text] [Related]
8. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report. Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K Surg Case Rep; 2018 Jul; 4(1):71. PubMed ID: 29978335 [TBL] [Abstract][Full Text] [Related]
10. Adrenal insufficiency following nivolumab therapy in patients with recurrent or metastatic head and neck cancer. Kagoshima H; Hori R; Kojima T; Okanoue Y; Fujimura S; Taguchi A; Shoji K Auris Nasus Larynx; 2020 Apr; 47(2):309-313. PubMed ID: 31235078 [TBL] [Abstract][Full Text] [Related]
11. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab]. Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129 [TBL] [Abstract][Full Text] [Related]
12. Secondary Adrenal Insufficiency Following Nivolumab Therapy in a Patient with Metastatic Renal Cell Carcinoma. Seki T; Yasuda A; Oki M; Kitajima N; Takagi A; Nakajima N; Miyajima A; Fukagawa M Tokai J Exp Clin Med; 2017 Sep; 42(3):115-120. PubMed ID: 28871578 [TBL] [Abstract][Full Text] [Related]
14. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab. Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791 [TBL] [Abstract][Full Text] [Related]
15. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis. Thapi S; Leiter A; Galsky M; Gallagher EJ J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065 [TBL] [Abstract][Full Text] [Related]
16. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report. Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440 [TBL] [Abstract][Full Text] [Related]
17. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy]. Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741 [TBL] [Abstract][Full Text] [Related]
18. [A Case of Nivolumab-Induced Isolated Adrenocorticotropic Hormone Deficiency Presenting Dyspnea]. Ito K; Uchida T; Manabe Y; Miyazaki Y; Itoh H; Mishina M; Okuno H Hinyokika Kiyo; 2018 Oct; 64(10):391-395. PubMed ID: 30543736 [TBL] [Abstract][Full Text] [Related]
19. [A case of metastatic gastric cancer showing long-term control with nivolumab after pseudoprogression]. Okamoto T; Ueda S Nihon Shokakibyo Gakkai Zasshi; 2021; 118(6):549-554. PubMed ID: 34108354 [TBL] [Abstract][Full Text] [Related]
20. [A Case of Long Survival with Hilar Lymph Node Metastasis from Gastric Cancer Successfully Treated with Nivolumab Immunotherapy]. Okada K; Takeoka T; Kobayashi K; Fukunaga M Gan To Kagaku Ryoho; 2019 Dec; 46(13):2315-2317. PubMed ID: 32156916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]